Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy +/- Bevacizumab in Breast Cancer
NCT00408408Phase 3Unknown
- Sponsor
- NSABP Foundation
- Start
- Nov 2006
- Primary completion
- Mar 2011
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors
- Countries
- 3
01
Overview
A Phase 3 trial of bevacizumab, capecitabine, gemcitabine in breast cancer, sponsored by NSABP Foundation. Status: unknown.
02
Drugs
bevacizumabcapecitabinegemcitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00408408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408408.